Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
Brunet
M
M
Toxicology Department, Hospital Clinic, University of Barcelona, Spain. mbrunet@medicine.ub.es
Torregrosa
J V
JV
Oppenheimer
F
F
Corbella
J
J
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016559:Tacrolimus / Q000097:blood* / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003404:Creatinine; D016559:Tacrolimus; D008775:Methylprednisolone